Trey Rutledge: Building a New Intelligence Layer for Healthcare

For Trey Rutledge, the case for quantum AI began with a question that has little to do with technology for its own sake: why should patients have to wait years for answers that science may already have the computational means to pursue?

That question became more difficult to ignore through conversations with physicians. Trey heard repeatedly about incomplete information, therapies still years from clinical availability, and biological data that could not always be connected when decisions needed to be made. His earlier work in blockchain and standards, including his time at Dragonchain and service with the IEEE Standards Association, had already taught him that sophisticated systems are valuable only when the structures around them make them trustworthy. Healthcare gave that lesson a much higher human cost.

As Co-Founder & President of Brilliancy Health, Trey now works across quantum computing, agentic AI, and healthcare, exploring how those technologies can be brought together to address problems that conventional computational approaches struggle to navigate. His interest lies particularly in the combinatorial complexity of chemistry and biology, where the number of possible interactions can quickly overwhelm conventional methods.

Quantum computing offered another computational pathway. Agentic AI offered a way to coordinate that capability. But for Trey, the real significance came when the two could operate together.

Completing Brilliancy's Quantum AI interface provided that moment. What had existed as an architectural possibility became something tangible: a continuous environment in which quantum resources and agentic intelligence could interact. It did not mean the problem had been solved. It meant that a possible route toward narrowing the distance between discovery and the patient had become visible.

That distinction is important to understanding Trey's approach. He is not interested in technology simply because it is new or powerful. The harder question is whether it can be made useful, transparent, and trustworthy enough for a field where the consequences of failure are profoundly human.

When Ambition Meets the Reality of Healthcare

Building such a system has required more than technical ambition. It has meant working within a sector where innovation must coexist with clinical caution, regulatory responsibility, data protection and the ethical weight of patient information.

In Brilliancy's formative period, the vision of bringing multi-vendor quantum capabilities together with multi-agent systems repeatedly encountered those realities. The technology could move in one direction while healthcare institutions, understandably, demanded evidence, safeguards, and accountability.

For Trey, that friction became a leadership lesson.

He began to see constraints differently. Rather than treating them as barriers standing in the way of innovation, he learned to treat them as information about what a system must be able to withstand before it can be trusted.

“The true measure of leadership is not the velocity of progress but the durability of trust once the system is under real pressure,” he says.

That idea now sits behind three principles that guide his leadership: humility in the face of complexity, collaboration across disciplines, and an uncompromising focus on human benefit.

It also explains why Trey does not see innovation and safety as opposing forces. In healthcare, the two have to advance together. A system that is technically impressive but difficult to trust has limited value. Equally, a system so cautious that it cannot meaningfully improve what clinicians can do has little reason to exist.

A Culture Built Across Disciplines

Trey's view of healthcare as a complex system extends directly into the way he builds teams.

Medicine does not operate like a linear production line. Decisions, biological processes, information, and outcomes interact across multiple levels. A useful technology therefore cannot be designed entirely within one discipline.

At Brilliancy, Trey looks for people who combine deep expertise with curiosity beyond their own field. Physicians need to be able to engage with quantum researchers. Engineers need to understand clinical urgency. Ethicists need enough technical understanding to challenge where capability might outpace responsibility.

That cross-disciplinary exchange is reinforced through culture. Psychological safety, in Trey's view, is not simply an employee benefit. It is part of the infrastructure required to surface better ideas. People need to feel able to question assumptions, challenge established thinking, and speak outside their formal areas of responsibility.

He takes a similar approach to developing future leaders.

Trey identifies emerging talent through expertise as well as a willingness to keep learning. Rather than relying on conventional top-down mentorship, he gives people meaningful responsibility within shared problems and allows them to work alongside colleagues from different disciplines.

Mentorship, however, is not one-directional. Trey sees it as reciprocal. His goal is not to create people who think like him, but leaders who can eventually go beyond what he has built without losing sight of the people the technology is intended to serve.

Making Complexity Computable

That philosophy is reflected in Brilliancy's Luminous Decision Intelligence Architecture.

According to Trey, the architecture brings together four distinct Agentic AI options with quantum gate access through IBM, IQM, IonQ, and D-Wave. The choice to work across multiple providers is deliberate. Rather than allowing the organization to become dependent on a single technological route, diversity is treated as a form of resilience.

The same thinking extends to security and accountability. Trey describes an architecture in which each agent is enclosed within post-quantum cryptography-enabled smart contracts designed to reduce critical attack surfaces and create immutable records of system activity.

The objective is not transparency as a marketing claim, but transparency as a property of the system itself. Clinicians, regulators, and other stakeholders should be able to understand what has happened and maintain confidence in how decisions are being supported.

The public-facing work of Brilliancy Health places that technology within a broader healthcare context. Brilliancy Health, a Brilliancy Quantum company, focuses on AI-powered hospital operations and modular intelligence designed to work with healthcare organizations and their existing systems. Its publicly described areas include hospital operations, EMS-to-hospital coordination, revenue and prior authorization, medication intelligence, and clinical intelligence.

That practical orientation is significant. For Trey, advanced computation cannot remain an isolated research exercise. It has to connect with the operational realities of healthcare, where systems already exist, clinicians already have workflows, and responsibility cannot simply be handed to an algorithm.

Innovation With a Measured Pace

Trey's approach to new opportunities is deliberately selective.

Before advancing a consequential idea, he asks whether it moves Brilliancy closer to reducing the interval between hypothesis and clinically meaningful insight. He then considers whether it can be implemented with continuous human oversight and full transparency. Finally, he asks whether it strengthens the trust of the people who will eventually depend on it.

The questions create a useful discipline around innovation.

Financial sustainability follows the same principle. It is necessary because a company must remain capable of pursuing its mission, but it is not the mission itself. Trey's preferred pace is deliberate: validate the technology, understand its limitations, and expand only when the evidence supports doing so.

That philosophy has helped shape Brilliancy's response to some of the field's most difficult challenges, including interoperability, data integrity, regulatory considerations, and post-quantum security. Rather than addressing each issue in isolation, the organization approaches them as connected parts of the environment in which the technology must function.

The result is a less spectacular but more durable view of innovation. The goal is not simply to demonstrate what technology can do. It is to establish what it can responsibly do.

From Possibility to Practice

The completion of the Quantum AI interface represented a significant shift for Brilliancy. The work moved beyond exploratory design toward an architecture intended to support hybrid workflows that combine quantum-enhanced simulation with agentic coordination.

Trey is careful about what that achievement does and does not prove.

The company has not claimed that it has already compressed the timelines of scientific discovery. Instead, the interface represents a step toward making that possibility testable in a more integrated environment.

That distinction is particularly important in a sector where enthusiasm can quickly outpace evidence.

Brilliancy's work with academic and clinical colleagues at KU Innovation Park has been part of the effort to address the practical questions surrounding the technology. Data integrity, interoperability, security, and regulatory prudence cannot be solved after deployment. They have to be considered while the architecture is being developed.

The next stage is therefore not simply about adding more computational capability. It is about demonstrating that the capability can operate responsibly within the complicated ecosystem of healthcare.

Preparing for the Next Phase of Quantum AI

The broader conversation around that transition will come into focus at the Brilliancy Health Summit on September 2, 2026, at KU Innovation Park in Lawrence, Kansas.

The event is expected to bring together healthcare leaders, policymakers, deep-tech specialists, and quantum researchers to examine the relationship between emerging technology and real-world care. For Trey, that kind of cross-disciplinary discussion is essential because the future of healthcare technology cannot be determined by technologists alone.

Several developments are likely to influence the field over the coming years: the practical maturation of hybrid quantum-classical systems, stronger expectations for verifiable transparency in agentic AI, the growing importance of post-quantum security, and wider recognition that healthcare functions as a complex adaptive system.

For Trey, these are not separate trends. Their significance lies in how they intersect.

Quantum computing may expand what can be explored computationally. Agentic AI may change how complex workflows are coordinated. Security and transparency may determine whether institutions are willing to rely on those systems. And an understanding of healthcare as an adaptive system may determine whether the technology is designed for the reality it is supposed to serve.

The opportunity, therefore, is not simply to make healthcare more computational. It is to make advanced computation more accountable to healthcare.

Measuring Technology by What It Gives Back

For all the complexity surrounding Trey's work, his ultimate measure of progress remains straightforward: what changes for the patient?

That question informs his advice to entrepreneurs and leaders entering the field. He encourages them to place humanity at the center of every calculation, build transparency into their systems, and create resilience rather than dependence on a single technological pathway.

He also cautions against treating computational power as an achievement in itself. Technology should be judged by what it gives back: less suffering, faster healing, greater clarity and more dignity in care.

It is a demanding standard, particularly for an emerging field whose possibilities are still being established.

Brilliancy has not yet shortened the discovery timelines that originally drew Trey toward this problem. But the completion of its Quantum AI interface has made the path forward more tangible. The architecture exists. The questions are becoming more precise. The next challenge is to demonstrate that the technology can move from computational possibility into trustworthy clinical application.

That may ultimately be the more meaningful test of quantum AI leadership.

Not how quickly a new technology can be introduced, but whether it can earn the confidence required to matter.

For Trey, the destination remains the same one that started the work: giving patients something technology too often promises but rarely delivers on its own: more time, greater clarity, and a more realistic possibility of better care.